Skip to main content
SpringerLink
Log in

Pretreatment with interferon-α does not appear to adversely affect survival after bone marrow transplantation (BMT) if discontinued ≥ 90 days before BMT

  • Clinical study
  • Published:
Inpharma Weekly

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pretreatment with interferon-α does not appear to adversely affect survival after bone marrow transplantation (BMT) if discontinued ≥ 90 days before BMT. Inpharma Wkly. 1223, 16 (2000). https://doi.org/10.2165/00128413-200012230-00035

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-200012230-00035

Keywords

Search

Navigation